medigraphic.com
Órgano Científico Oficial de SOCIEM-UCV

2009, Number 4

Next >>

Acta Cient Estud 2009; 7 (4)

Health area students’ knowledge regarding use of Human Papiloman Virus vaccine

Hidalgo SJ, Muñoz ZG

Language: Spanish
References: 22
Page: 233-237
PDF size: 147.01 Kb.


ABSTRACT

No abstract


REFERENCES

  1. Infectología clínica kumate-Gutiérrez 17 ed. 2008 Méndez editores pp. 382-383

  2. Gérvas J. “La incierta prevención del cáncer de cuello de útero con la vacuna contra el virus del papiloma humano”. Rev Port Clin Geral 2007;23(9):547-55.

  3. Robert Steinbrook, M.D.”The Potential of Human Papillomavirus Vaccines” New England Journal of Medicine. 2006;16(6):354-11

  4. Koutsky K.A; Cosette M.W; Brown M.D.A controlled trial of a human papillomavirus type 16 vaccine” The New England Journal of Medicine. 2002;347(21):1645-51.

  5. The Future Study Group, “Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions”. The New England Journal of Medicine. 2007 vol. 356(10):19.

  6. Deborah Bateson, Kirsten Mc Caffery, S Rachel Skinner, “HPV vaccination catch up program Utilisation by young Australian women”. Australian Family Physician. 2009;38(12):122-34

  7. Darron R. Brown, Susanne K. Kjaer, Kristján Sigurdsson, Ole-Erik Iversen, Mauricio Hernandez- Avila, Cosette M. Wheeler, Gonzalo Perez, Laura A. Koutsky, The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16–26 Years”. The Journal of Infectious Diseases. 2009;199(1):926–35.

  8. Subhashini Jagu , Balasubramanyam Karanam , Ratish Gambhira , Sudha V. Chivukula , Revathi J. Chaganti , Douglas R. Lowy , John T. Schiller, “Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines”. JNCI. 2009;101(11):2

  9. Lisa Rambout BSc Phm, Laura Hopkins MD MSc, Brian Hutton MSc, Dean Fergusson PhD, “Prophylactic vaccination against human papilomavirus infection and disease in women: a systematic review of randomized controlled trials” CMAJ. 2007;177(5):111-26

  10. David Soper, “Reducing the Health Burden of HPV Infection Through Vaccination”Hindawi Publishing Corporation Infectious Diseases in Obstetrics and Gynecology. 2006;83(4):1–5

  11. Shiwen Peng, Todd T. Tomson, T-C Wu. “A Combination of DNA Vaccines Targeting Human Papillomavirus Type 16 E6 and E7 Generates Potent Antitumor Effects” Gene Ther. 2006;13(3): 257–265.

  12. Vandana A Govan. “A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6,

  13. 11, 16 and 18) recombinant vaccine (Gardasil®)”. Therapeutics and Clinical Risk Management 2008:4(1) 65–70

  14. Gina S. Ogilvie MD, Valencia P. Remple, Fawziah Marra, Shelly A. McNeil, Monika Naus MD, Karen L. Pielak MSN, Thomas G. Ehlen, Simon R. Dobson, Deborah M. Money, David M. Patrick. “Parental intention to have daughters receive the human papillomavirus vaccine”. CMAJ.2007;177(12)1112-7

  15. Loretta Brabin, Stephen A Roberts2 and Henry C Kitchener, “A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent”. BMC Public Health. 2007;7(1):20

  16. Camille C Ragin, Robert P Edwards, Jade Jones, Natalie E Thurman, Aletha Akers, Susanne M Gollin, Dwight E Heron, Cecile Andraos-Selim, Cornelius Bondzi, Linda Robertson and Emanuela Taioli, “Knowledge about human papillomavirus and the HPV vaccine – a survey of the general population”. Infectious Agents and Cancer. 2009; 4(1):10

  17. Charlotte Devereaux Walsh, Aradhana Gera, Meeraj Shah, Amit Sharma,Judy E Powell and Sue Wilson. “Public knowledge and attitudes towards Human Papilloma Virus (HPV) vaccination”. BMC Public Health 2008,8(4):368

  18. Mcomanda F. Dempsey, MD, PhD, MPH. “Human Papillomavirus: The Usefulness of Risk Factors in Determining Who Should Get Vaccinated”.. Rev Obstet Gynecol. 2008;2(6):12-9

  19. Kari P. Braaten,. “Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine”. Rev Obstet Gynecol. 2008;1(1):2-10

  20. E. Comín Bertrán. “Vacuna contra el virus del papiloma humano. No es oro todo lo que reluce.”. Aten Primaria. 2008;40(6):311-8

  21. Viviana Leiro, Alcira Bermejo, “HPV vaccines” Banfi eld - Pcia. de Buenos Aires - Rep. Argentina. 2008;64(2):41-9.

  22. Castellsagué, FX. Bosch. “Vacunas frente al virus del papiloma humano (VPH): incorporación del pediatra en la lucha contra el cáncer de cuello uterino”. Rev Pediatr Aten Primaria. 2007;9(3):21-42




2020     |     www.medigraphic.com